ロード中...

Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

BACKGROUND: Multiple sclerosis (MS) is a chronic disease that may require decades of ongoing treatment. Therefore, the long-term safety and efficacy of disease-modifying therapies is an important consideration. METHODS: The LONGTERMS study evaluated the safety and efficacy of fingolimod in patients...

詳細記述

保存先:
書誌詳細
出版年:Ther Adv Neurol Disord
主要な著者: Cohen, Jeffrey A., Tenenbaum, Nadia, Bhatt, Alit, Zhang, Ying, Kappos, Ludwig
フォーマット: Artigo
言語:Inglês
出版事項: SAGE Publications 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763939/
https://ncbi.nlm.nih.gov/pubmed/31598139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419878324
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!